Use of Monoclonal Antibodies (mAbs) by EMS agencies in our region is ENTIRELY OPTIONAL.  mAbs reduce the risk of hospitalization and death in COVID-19 patients by 71%. These drugs take up to 2 hours to deliver to a patient via IV or subcutaneous injection. Please use this survey to indicate if your agency would CONSIDER administering mAbs.  This DOES NOT COMMIT YOU TO DO SO.

Question Title

* 1. Name

Question Title

* 2. Agency

Question Title

* 3. Phone Number

Question Title

* 4. Email

Question Title

* 5. Would your agency be willing to CONSIDER delivering MABs at various locations within your jurisdiction?

Question Title

* 6. Would your agency CONSIDER administration of mAbs at locations outside your jurisdiction on a mutual aid basis?

T